IART
$46.95
Integra Lifesciences
$1.43
3.14%
IART
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $0.54
Revenue:  $342.83 Mil
Monday
Nov 9
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when IART reports earnings?
Beat
Meet
Miss

Where is IART's stock price going from here?
Up
Flat
Down
Stock chart of IART
Analysts
Summary of analysts' recommendations for IART
Score
Grade
Pivots
Resistance
$49.35
$48.17
$47.56

$46.38

Support
$45.77
$44.59
$43.98
Tweet
Growth
Description
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don't have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients - and surgeons.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWatersCardiovascular SystemsTeleflex3MHill-Rom Holdings